CMIC Group, a pioneer and a leading CRO (Contract Research Organizations) in Japan, announced on 10 July 2019, that the company joined Align Clinical CRO, a life sciences industry standards group dedicated to creating open technology standards that make it easier for sponsors and contract research organizations (CROs) to work together during trials. CMIC is the first Japan-based CRO to join the group, bringing more than 25 years of solution provider experience and clinical trial operational expertise in Asia.

CMIC is joining forces with leading CROs partners to improve execution and collaboration with life sciences companies during trials. With end-to-end solutions from preclinical to clinical, from drug development to manufacturing, and from filing to post-marketing surveillance, CMIC is a strategic partner to help sponsors develop better medicine faster.

“The global healthcare industry is going through significant change. The types of service requests and qualification requirements are changing, the number of global trials is increasing, and study designs are more complex,” said Keiko Oishi, President and COO of CMIC HOLDINGS Co., Ltd. “As a member of Align Clinical CRO, CMIC is committed to helping the industry increase productivity, reduce operational costs, and run clinical trials more efficiently.”